Actualites therapeutiques en cardiologie

[en] Cardiovascular diseases are the leading cause of mortality in the so-called industrial countries. An appropriate management is mandatory and its modalities should be known and applied by physicians. European and American recommendations are regularly published and updated. They are available on the web sites of the European Society of Cardiology (www.escardio.org), the American Heart Association (www.aha.org) and the American College of Cardiology (www.acc.org This article describes the recent therapeutic options of some cardiovascular diseases, especially coronary artery disease, valvular diseases, atrial fibrillation and implantable defibrillator, but is far to be exhaustive.

Disciplines :

Cardiovascular & respiratory systems
Cardiovascular & respiratory systems

Author, co-author :

Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Waleffe, André ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie

Pierard, Luc ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Language :

French

Title :

Actualites therapeutiques en cardiologie

Alternative titles :

[en] New Therapeutic Guidelines in Cardiology

Publication date :

2007

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Université de Liège. Revue Médicale de Liège, Liège, Belgium

Volume :

Issue :

5-6, May-Jun

Pages :

244-53

Peer reviewed :

Peer reviewed

Available on ORBi :

since 21 June 2013

Statistics

Number of views

63 (6 by ULiège)

Number of downloads

31 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

Bibliography

Daemen J, Wenaweser P, Tsuchida K, et al. - Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice : data from a large two-institutional cohort study. Lancet, 2007, 369, 667-678.
Ruzyllo W, Tendera M, Ford I, et al. - Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris : a 3-month randomised, double-blind, multicentre, noninferiority trial. Drugs, 2007, 67, 393-405.
Bhatt DL, Fox KA, Hacke W, et al. - Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med, 2006, 354, 1706-1717.
Boden WA, O'Rourke RA, Teo KX, et al for the COURAGE Trial Research Group. - Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med, 2007, 356, 1503-1516.
Barter PJ, Kastelein JJ. - Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. J Am Coll Cardiol, 2006, 47, 492-499.
Nissen SE, Tardif JC, Nicholls SJ, et al. - Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med, 2007, 356, 1304-1316.
Scheen AJ, Finer N, Hollander P, et al. - Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes : a randomised controlled study. Lancet, 2006, 368, 1660-1672.
Gibbons RJ, Fuster V. - Therapy for patients with acute coronary syndromes - New opportunities. N Engl J Med, 2006, 354, 1524-1527.
Vahanian A, Baumgartner H, Bax J, et al. - Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J, 2007, 28, 230-268.
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 Guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol, 2006, 48, 1-148.
Cribier A, Eltchaninoff H, Tron C, et al. - Percutaneous implantation of aortic valve prosthesis in patients with calcific aortic stenosis: technical advances, clinical results and future strategies. J Interv Cardiol, 2006, 19, S87-96.
Pellikka PA, Sarano ME, Nishimura RA, et al. - Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation, 2005, 111, 3290-3295.
Das P, Rimington H, Chambers J. - Exercise testing to stratify risk in aortic stenosis. Eur Heart J, 2005, 26, 1309-1313.
Lancellotti P, Lebois F, Simon M, et al. - Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation, 2005, 112, 1377-1382.
Bergler-Klein J, Klaar U, Heger M, et al. - Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation, 2004, 109, 2302-2308.
Lim P, Monin JL, Monchi M, et al. - Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J, 2004, 25, 2048-2053.
Kearney PM, Baigent C. - Statins : are any questions unanswered ? Curr Opin Lipidol, 2006, 17, 418-425.
Cowell SJ, Newby DE, Prescott RJ and Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. - A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med, 2005, 352, 2389-2397.
Moura LM, Ramos SF, Zamorano JL, et al. - Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol, 2007, 49, 554-561.
Monin JL, Quere JP, Monchi M et al. - Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation, 2003, 108, 319-324.
Quere JP, Monin JL, Levy F, et al. - Influence of preoperative left ventricular contractile reserve on postoperative ejection fraction in low-gradient aortic stenosis. Circulation, 2006, 113, 1738-1744.
Monin JL, Dehant P, Roiron C, et al. - Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes diagnostic accuracy and outcome implications. J Am Coll Cardiol, 2005, 46, 302-309.
Rosenhek R, Rader F, Klaar U, et al. - Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation, 2006, 113, 2238-2244.
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. - Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med, 2005, 352, 875-883.
Detaint D, Messika-Zeitoun D, Avierinos JF, et al. - B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation, 2005, 111, 2391-2397.
Herrmann HC, Rohatgi S, Wasserman HS, et al. - Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv, 2006, 68, 821-828.
Lancellotti P, Troisfontaines P, Toussaint AC, et al. - Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation, 2003, 108, 1713-1717.
Lancellotti P, Gerard PL, Pierard LA. - Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J, 2005, 26, 1528-1532.
Pierard LA, Lancellotti P. - The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med, 2004, 351, 1627-1634.
Evangelista A, Tornos P, Sambola A, et al. - Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med, 2005, 353, 1342-1349.
Van Camp G, Flamez A, Cosyns B, et al. - Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet, 2004, 363, 1179-1183.
Zanettini R, Antonini A, Gatto G, et al. - Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med, 2007, 356, 39-46.
Go AS, Hylek EM, Phillips Ka, et al. - Prevalence of diagnosed atrial fribrillation in adults : national implications for rhythm management and stoke prevention : the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001, 285, 2370-2375.
Furberg CD, Psaty BM, Manolio, et al. - Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol, 1994, 74, 236-241.
Stewart S, Hart CL, Hole DJ, et al. - A population-based study of the long-term risks associated with atrial fibrillation : 20-year follow-up of the Renfrew/Paisley study. AM J Med, 2002, 113, 359-364.
Hart RG, Halperin JL. - Atrial fibrillation and thromboembolism : a decade of progress in stroke prevention. Ann Intern Med, 1999, 131, 688-695.
Healey JS, Baranchuk A, Crystal E, et al. - Prevention of atrial fibrillation with angiotensin- converting enzyme inhibitors and angiotensin receptor blockers : a meta-analysis. J Am Coll Cardiol, 2005, 45, 1832-1839.
Haissaguerre M, Jais P, Shah DC, et al. - Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med, 1998, 339, 659-666.
Stollberger C, Chnupa P, Kronik G, et al. - Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. Ann Intern Med, 1998, 128, 630-638.
Van Gelder IC, Hagens VE, Bosker HA, et al. - A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl Med, 2002, 347, 1834-1840.
Carlsson J, Miketic S, Windeler J, et al. - Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation : the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol, 2003, 41, 1690-1696.
Wyse DG, Waldo AL, DiMarco JP, et al. - A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002, 347, 1825-1833.
Cox JL, Canavan TE, Schuessler RB, et al. - The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter ad atrial fibrillation. J Thorac Cardiovasc Surg, 1991, 101, 406-426.
Fuster V, Ryden LE, Cannom DS, et al. - ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - executive summary : a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol, 2006, 48, 854-906.
Zipes DP, Camm AJ, Borggrefe M, et al. - ACC/AHA/ESC 2006 guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death : Executive Summary. J Am Coll Cardiol, 2006, 48, 1064-1108, Circulation, 2006, 114, 1088-1132
and Eur Heart J, 2006, 27, 2099-2140.
Moss AJ, Zareba W, Hall WJ, et al. - Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002, 346, 877-883.
Kadish A, Dyer A, Daubert JP, et al. - for the defibrillators in non-ischemic cardiomyopathy treatment evaluation (DEFINITE). Prophylactic defibrillator implantation in patients with non-ischemic dilated cardiomyopathy. N Engl J Med, 2004, 350, 2151-2158.
Bardy GH, Lee KL, Mark DB, et al. - Sudden Cardiac Dearh in Heart Failure Trial (SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005, 352, 225-237.